News
June 7, 2010. Phytomedics Press Release.
Dr. Jacques-Pierre Moreau Joins Phytomedics Inc. Board of Directors
April 28, 2010. Phytomedics Press Release.
Phytomedics Inc. to Present at BIO 2010 International Convention
August 19, 2009. Phytomedics Press Release.
Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
April 17, 2008. Phytomedics Press Release.
Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD, as President and Chief Executive Officer
July 26, 2007. Phytomedics Press Release.
Phytomedics Inc. Announces that Arthur H. Finnel will join its Senior Management Team as Chief Financial Officer
June 11, 2007. Phytomedics Press Release.
Phytomedics Inc. Announces Series B Funding of US $9 Million to Start Development of its Phase III Drug Candidate for Rheumatoid Arthritis
November 29, 2006. Phytomedics Press Release.
Phytomedics Inc. Novel Oral Disease Modifying Drug Candidate PMI-001 Demonstrates Positive Phase II Results in Rheumatoid Arthritis
August 1, 2006. Phytomedics Press Release.
Ilan Kaufthal, Vice Chairman of Investment Banking, Bear, Stearns & Co., Joins Phytomedics Inc. Board of Directors
April 7, 2006. Phytomedics Press Release.
G. Steven Burrill, CEO, Burrill & Company, Joins Phytomedics Inc. Board of Directors
April 6, 2006. Phytomedics Press Release.
Dr. Gunnar Weikert, Chairman, CEO and Founder of Inventages Venture Capital Investments Inc., Joins Phytomedics Inc. Board of Directors
March 29, 2006. Phytomedics Press Release.
Phytomedics Inc. Announces Appointment of Pharmaceutical Industry Veteran Aki von Roy to the Position of Chairman of Its Board of Directors
November 21, 2005. Phytomedics Press Release.
Phytomedics Inc. Announces Appointment of Pharmaceutical Industry Veteran Dr. Mark W. Pierce, MD, PhD. to its Board of Directors
August 31, 2005. Phytomedics Press Release.
Phytomedics Inc. Announces Collaboration with McNeil Nutritionals, LLC to Develop and Commercialize Botanical Therapeutics
June 15, 2005. Phytomedics Press Release.
Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System.
